Image credit: Jasleen Kaur

GW Pharmaceuticals and GNC met with White House on CBD

One company is focused on the future of CBD in supplements. The other, on its future in pharmaceuticals.

CBD
Regulation, Research

FDA Researchers Publish First Study on Medical Cannabis Testing Patchwork

The research comes amid a broader agency effort to collect data on cannabinoids, which will help shape forthcoming rules on approved products.

Lobbying

From Sheet Metal to Beef, Cannabis Draws Diverse Lobbying Interests

Each year, the list of entities lobbying on cannabis grows longer. And, more diverse.